Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 15 July 2009, doi:10.1136/bmj.b2828
Cite this as: BMJ 2009;339:b2828
| The first 150 words of the full text of this article appear below. |
Brown and colleagues report 93% sensitivity and 86% specificity for their self administered screening test for Alzheimers disease.1 They conclude that "it is a powerful and valid screening test for the detection of Alzheimers disease."
However, doctors and lay people are often confused by such conditional probabilities,2 3 and the value of a screening test is best appreciated when statistics are expressed in natural frequencies. For infrequent disorders, even high values of sensitivity and specificity can lead to an unacceptable number of false positives.
The accompanying editorial gives an expected prevalence of 13 cases of Alzheimers disease in 1000 people aged 65-69.4 Using this as the base rate together with the figures for sensitivity and specificity, I calculated test results in natural frequencies. For every individual correctly declared to have Alzheimers disease, about 11, on average, will be falsely declared to have this dread disease.
This test is likely to become
Stephen L Black, retired (emeritus) professor of psychology1
1 Bishops University, Sherbrooke, Quebec, Canada J1M 1Z
sblack@ubishops.ca